Scholarlink

Background <p>Tumour cells enhance their survival and proliferation through autocrine and paracrine signalling, thereby facilitating tumour progression. Sustained growth requires the formation of new blood vessels, making angiogenesis a major therapeutic target. Concurrently, tumour development involves metabolic reprogramming to support uncontrolled proliferation. While the role of tumour metabolism in immune regulation has been widely studied, its contribution to angiogenesis remains less understood.</p> Objective <p>To summarize current knowledge on how tumour-driven lipid metabolic reprogramming influences angiogenesis within the tumour microenvironment (TME) and to identify potential therapeutic opportunities.</p> Methods <p>We reviewed recent studies focusing on the intersection between tumour lipid metabolism and angiogenesis, integrating findings from experimental and translational research.</p> Results <p>Emerging evidence indicates that lipid metabolic alterations in tumour cells modulate endothelial function, vascular remodelling, and pro-angiogenic signalling pathways. These changes reshape the angiogenic landscape of the TME, contributing to tumour progression and therapy resistance.</p> Conclusion <p>Understanding the interplay between lipid metabolism and angiogenesis may uncover novel therapeutic vulnerabilities. Targeting metabolic reprogramming in the TME could provide new avenues for anti-angiogenic strategies and improve patient outcomes.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The impact of lipid metabolism remodeling in the tumor microenvironment on angiogenesis

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年2月25日

查看全文
  • Chen Ye,
  • Zhongqun Wang,
  • Lihua Li

摘要

Background

Tumour cells enhance their survival and proliferation through autocrine and paracrine signalling, thereby facilitating tumour progression. Sustained growth requires the formation of new blood vessels, making angiogenesis a major therapeutic target. Concurrently, tumour development involves metabolic reprogramming to support uncontrolled proliferation. While the role of tumour metabolism in immune regulation has been widely studied, its contribution to angiogenesis remains less understood.

Objective

To summarize current knowledge on how tumour-driven lipid metabolic reprogramming influences angiogenesis within the tumour microenvironment (TME) and to identify potential therapeutic opportunities.

Methods

We reviewed recent studies focusing on the intersection between tumour lipid metabolism and angiogenesis, integrating findings from experimental and translational research.

Results

Emerging evidence indicates that lipid metabolic alterations in tumour cells modulate endothelial function, vascular remodelling, and pro-angiogenic signalling pathways. These changes reshape the angiogenic landscape of the TME, contributing to tumour progression and therapy resistance.

Conclusion

Understanding the interplay between lipid metabolism and angiogenesis may uncover novel therapeutic vulnerabilities. Targeting metabolic reprogramming in the TME could provide new avenues for anti-angiogenic strategies and improve patient outcomes.